Bausch Health has developed a new treatment for acne, and the drug plan now covers this treatment for beneficiaries of the Correctional Service of Canada.
4 reports, 1 independent
Updated Aug 21
Gone quiet
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bausch Health has developed a new treatment for acne, and the drug plan now covers this treatment for beneficiaries of the Correctional Service of Canada.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Coverage
Newest first; wire copies grouped- ACCESS NewswireBausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel), Now Available Through Public Drug Plans of Quebec and Saskatchewan
- ACCESS NewswireCORRECTING and REPLACING: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans o
- Unknown outlet
- Unknown outlet